JPH05246873A - Agent for improving hepatic function and for preventing hangover - Google Patents

Agent for improving hepatic function and for preventing hangover

Info

Publication number
JPH05246873A
JPH05246873A JP4084727A JP8472792A JPH05246873A JP H05246873 A JPH05246873 A JP H05246873A JP 4084727 A JP4084727 A JP 4084727A JP 8472792 A JP8472792 A JP 8472792A JP H05246873 A JPH05246873 A JP H05246873A
Authority
JP
Japan
Prior art keywords
agent
extract
asparagus
linearis
hepatic function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4084727A
Other languages
Japanese (ja)
Inventor
Kunihiko Kato
邦彦 加藤
Masatoshi Nakano
昌俊 中野
Masahiro Kishikawa
正大 岸川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RUIBOSUTEII JAPAN KK
Original Assignee
RUIBOSUTEII JAPAN KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RUIBOSUTEII JAPAN KK filed Critical RUIBOSUTEII JAPAN KK
Priority to JP4084727A priority Critical patent/JPH05246873A/en
Publication of JPH05246873A publication Critical patent/JPH05246873A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE:To provide the hepatic function-improving and treating agent containing the extract of Asparagus.linearis as an active ingredient, not causing adverse actions, capable of rapidly treating the hepatic diseases, having excellent safety, and useful as a hangover and drunken sickness-preventing agent such as acute alcoholism diseases, etc. CONSTITUTION:The objective hepatic function-improving and treating agent contains as an active ingredient an Asparagus.linearis extract which is obtained e.g. by adding a 50-1000 times volume of water to the leaves or stems of the Asparagus.linearis belonging to the genus Leguminosae, boiling the mixture, further boiling and extracting the mixture for 5-30min and subsequently subjecting the treated mixture to a lyophilization, etc. The agent is preferably drunk at a dose of 100-1500ml/day as a solution of 1-5g dried leaves/liter, when commonly administered as a beverage.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、マメ科に属するアスパ
ラサス・リネアリスの含有成分を有効成分とする肝機能
改善治療および2日酔い・悪酔い防止剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a liver function improving treatment and an agent for preventing hangover / sickness, which contains asparagus linealis, a member of the legume family, as an active ingredient.

【0002】[0002]

【従来の技術】従来より,2日酔いに関する薬剤として
はいくつか知られている。
2. Description of the Related Art Heretofore, there have been known some medicines for hangover.

【0003】[0003]

【発明が解決しようとする課題】しかし、従来の2日酔
いに関する薬剤は、2日酔いの改善に重点がおかれてい
るにもかかわらず、二日酔いや悪酔いを改善するには効
果が十分でなかった。
However, even though the conventional drugs for hangover are focused on improving hangover, they are not sufficiently effective to improve hangover and sickness. It was

【0004】また、従来の2日酔い・悪酔い改善剤は、
主に胃のむかつき等を緩和する胃腸剤的要素が強く、2
日酔いを防止したり、悪酔いを防止することはできなか
った。
The conventional hangover / sickness remedy is
Mainly due to its strong gastrointestinal properties that relieve upset stomach, etc. 2
It was not possible to prevent sunsickness or sickness.

【0005】本発明は、肝機能を促進し、肝臓疾患、急
性アルコール中毒改善を図り2日酔い・悪酔い改善およ
び防止に有効な組成物を提供することを目的とする。
It is an object of the present invention to provide a composition which promotes liver function, improves liver diseases and acute alcohol poisoning, and is effective in improving and preventing hangover / sickness.

【0006】そこで、本発明者らは、前記目的を解決す
るために鋭意研究を重ねた結果、マメ科に属するアスパ
ラサス・リネアリス抽出物が、肝臓疾患、特に急性アル
コール中毒あるいは2日酔いに対し優れた効果を有し、
かつ副作用がなく安全に肝臓疾患を改善できるとの知見
を得て本発明を完成した。
[0006] Therefore, as a result of intensive studies to solve the above-mentioned object, the present inventors have found that an Aspalathus linealis extract belonging to the legume family is effective against liver diseases, especially acute alcohol poisoning or hangover. Has an excellent effect,
The present invention has been completed based on the finding that there is no side effect and that liver disease can be safely ameliorated.

【0007】本発明の有効成分は、アスパラサス・リネ
アリスの抽出液からなり、抽出法としては、アスパラサ
ス・リネアリスの葉または茎を水及び/または有機溶媒
で抽出し、該抽出液より抽出溶媒を留去する方法、また
はアスパラサス・リネアリスの葉または茎を粉砕するこ
とによって得ることができる。また、通常の日本茶、中
国茶、紅茶などの製法と同様に抽出してもよい。
The active ingredient of the present invention comprises an extract of Aspalathus linealis. As an extraction method, leaves or stems of Aspalathus linealis are extracted with water and / or an organic solvent, and the extraction solvent is extracted from the extract. Can be obtained by distilling off or by crushing leaves or stems of Aspalathus linealis. In addition, it may be extracted in the same manner as in the production method of ordinary Japanese tea, Chinese tea, black tea and the like.

【0008】水で抽出する場合には、アスパラサス・リ
ネアリスの50〜1000倍の水を加え、沸騰後、さら
に5〜30分程度沸騰抽出するのが好ましい。また、通
常の茶と同様抽出するときは、アスパラサス・リネアリ
スの乾燥葉の50〜500倍の水を加え、90〜100
度で3〜30分程度放置して抽出液を得る。
In the case of extraction with water, it is preferable to add 50 to 1000 times as much water as Aspalathus linealis, boil and then carry out boiling extraction for about 5 to 30 minutes. Also, when extracting in the same manner as ordinary tea, add 50 to 500 times the water of dried leaves of Aspalathus linearias and add 90 to 100
The extract is obtained by leaving it for about 3 to 30 minutes.

【0009】有機溶媒の具体例としては、メタノール、
エタノール、アセトン等が挙げられ、抽出にあたっては
温時抽出等慣用手段を用いることができる。また、抽出
液の分離も、デカンテーションや遠心分離等の慣用手段
を用いることができる。
Specific examples of the organic solvent include methanol,
Ethanol, acetone and the like can be mentioned, and conventional means such as warm extraction can be used for extraction. Further, for the separation of the extract, conventional means such as decantation or centrifugation can be used.

【0010】抽出溶媒の留去も凍結乾燥等の慣用手段を
用いることができる。また、アスパラサス・リネアリス
そのものを粉砕し、粉末化して用いることもできる。
A conventional means such as freeze-drying can be used for distilling off the extraction solvent. Also, Aspalathus linealis itself can be crushed and powdered for use.

【0011】本組成物は、有効成分を生理学的に許容さ
れうる担体、賦形剤、結合剤、希釈剤と混合し、たとえ
ば顆粒剤、粉剤、硬カプセル剤、軟カプセル剤、塗布
剤、シロップ、坐剤、注射剤として経口または非経口的
に、または、混合してそのまま溶液、粉末顆粒、錠剤、
乳剤、ゼリー状など任意の形態で単独投与、濃縮液を利
用、または他の飲食物に混合して飲食することもでき
る。
The composition is prepared by mixing the active ingredient with physiologically acceptable carriers, excipients, binders and diluents, for example granules, powders, hard capsules, soft capsules, coatings and syrups. , Suppositories, orally or parenterally as injections, or as a mixture as it is, solutions, powder granules, tablets,
It can be administered alone in any form such as an emulsion or jelly, can be used as a concentrated solution, or can be mixed with other foods and drinks.

【0012】投与量は、対象となる疾患の種類、程度に
より異なるが、飲料として常用する場合には、1〜5g
乾燥葉/1溶液を100ml〜1500ml/日飲食す
るのが好ましい。
The dose varies depending on the type and degree of the target disease, but in the case of regular use as a drink, 1 to 5 g
It is preferable to eat and drink 100 ml to 1500 ml / day of the dried leaf / 1 solution.

【0013】アスパラサス・リネアリスは、ラットに対
する急性毒性試験で死亡例は皆無であり、生化学血液検
査および病理組織学的検査においても異常が認められな
かった。
[0013] Aspalathus linealis showed no death in an acute toxicity test in rats, and no abnormality was observed in biochemical blood tests and histopathological tests.

【0014】[0014]

【効果】本発明は、ヒトを含む哺乳動物の肝臓疾患、特
に急性アルコール中毒疾患を飲食等により副作用無く、
迅速に改善す治療することができる。
[Effects] The present invention is effective for liver diseases of mammals including humans, particularly acute alcohol poisoning diseases by eating and drinking without side effects.
Can be quickly improved and treated.

【0015】[0015]

【実施例】【Example】

製造例 採取したアスパラサス・リネアリスの葉(茎つき)を、
5mm長に切断後、ローリング、酵素醗酵、天日乾燥の
工程を経て乾燥葉とする。乾燥葉4gを水1.5リット
ルで15分間沸騰させ抽出液を得た。
Production example Collected Aspalathus linealis leaves (with stem)
After cutting to a length of 5 mm, dried leaves are subjected to the steps of rolling, enzyme fermentation, and sun drying. 4 g of dried leaves were boiled with 1.5 liters of water for 15 minutes to obtain an extract.

【0016】実施例1 製造例で得たアスパラサス・リネアリスを各種酒気おび
者および泥酔者にコップ数杯飲ませ、1時間以内の酔い
状態の改善および2日酔いの有無を調べた。その結果を
表1に示す。
Example 1 Various asparagus linearias obtained in the production example were drunk by various drinkers and drunks to drink several cups, and the improvement of the sickness state within 1 hour and the presence or absence of a hangover were examined. The results are shown in Table 1.

【表1】 [Table 1]

【0017】実施例2 製造例で得たアスパラサス・リネアリスの抽出液を3カ
月間マウスに自由摂取で水のかわりに飲ませた抽出液群
と、通常の水を飲ませたコントロール群につき、賭殺後
肝臓グリコーゲン量の蓄積の程度を顕微鏡で調べた。そ
の結果を表2に示す。
Example 2 An extract group obtained by allowing mice to freely drink the extract of Aspalathus linealis obtained in the production example for 3 months instead of water, and a control group containing ordinary water After betting, the extent of accumulation of liver glycogen content was examined microscopically. The results are shown in Table 2.

【表2】 表2より、抽出液を飲ませた抽出液群は、コントロール
に比べて肝臓グリコーゲン蓄積がほとんどのマウスで認
められ、肝機能代謝が促進されたことが明らかになっ
た。
[Table 2] From Table 2, it was revealed that in the extract group in which the extract was drunk, hepatic glycogen accumulation was observed in most of the mice as compared with the control, and liver functional metabolism was promoted.

【0018】アスパラサス・リネアリスの化学分析結果
は下記の通りである。 鉄 23.40mg/100g カルシウム 187.00mg/100g カリウム 398.00mg/100g マグネシウム 207.00mg/100g 銅 2.25ppm 亜鉛 6.74ppm セレン 0.13ppm ビタミンE 17.00mg/100g たんぱく質 8.00% フラボノイド 41.00mg/100g 抗酸化能・SOD様力価 69,000unit/g 酸不溶性蛋白成分 150mg/100g 香気成分 100mg/100g 糖含有化合物 690mg/100g
The results of chemical analysis of Aspalathus linealis are as follows. Iron 23.40 mg / 100 g Calcium 187.00 mg / 100 g Potassium 398.00 mg / 100 g Magnesium 207.00 mg / 100 g Copper 2.25 ppm Zinc 6.74 ppm Selenium 0.13 ppm Vitamin E 17.00 mg / 100 g Protein 8.00% Flavonoids 41 0.000 mg / 100 g Antioxidant / SOD-like potency 69,000 unit / g Acid-insoluble protein component 150 mg / 100 g Aroma component 100 mg / 100 g Sugar-containing compound 690 mg / 100 g

【0019】また香気成分として、カルボニル化合物
(15%)、カロチノイド分解物(17%)、炭素数2
〜12の有機酸(22%)、フェノール化合物(13
%)、芳香族含酸素化合物(7%)、芳香族炭化水素
(5.5%)、テルペノイド(4%)などを含有する。
なお、酸不溶性蛋白質とは比較的分子量の大きな蛋白成
分である。
As aroma components, carbonyl compound (15%), carotenoid decomposition product (17%), carbon number 2
~ 12 organic acids (22%), phenolic compounds (13
%), Aromatic oxygen-containing compounds (7%), aromatic hydrocarbons (5.5%), terpenoids (4%) and the like.
The acid-insoluble protein is a protein component having a relatively large molecular weight.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 中野 昌俊 愛知県知立市新林町茶野36−16 (72)発明者 岸川 正大 長崎県長崎市虹ケ丘町16−16 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Masatoshi Nakano 36-16 Chano, Shinbayashi-cho, Chiryu-shi, Aichi (72) Inventor Masahiro Kishikawa 16-16 Nijigaoka-cho, Nagasaki-shi, Nagasaki

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 アスパラサス・リネアリス抽出物を有効
成分とする肝臓機能改善治療剤
1. A therapeutic agent for improving liver function, comprising an Aspalathus linealis extract as an active ingredient.
JP4084727A 1992-03-06 1992-03-06 Agent for improving hepatic function and for preventing hangover Pending JPH05246873A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4084727A JPH05246873A (en) 1992-03-06 1992-03-06 Agent for improving hepatic function and for preventing hangover

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4084727A JPH05246873A (en) 1992-03-06 1992-03-06 Agent for improving hepatic function and for preventing hangover

Publications (1)

Publication Number Publication Date
JPH05246873A true JPH05246873A (en) 1993-09-24

Family

ID=13838724

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4084727A Pending JPH05246873A (en) 1992-03-06 1992-03-06 Agent for improving hepatic function and for preventing hangover

Country Status (1)

Country Link
JP (1) JPH05246873A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002080388A (en) * 2000-09-04 2002-03-19 Takeda Food Products Ltd Activation agent for liver function
CN109663031A (en) * 2019-02-15 2019-04-23 武汉职业技术学院 A kind of sobering-up composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002080388A (en) * 2000-09-04 2002-03-19 Takeda Food Products Ltd Activation agent for liver function
CN109663031A (en) * 2019-02-15 2019-04-23 武汉职业技术学院 A kind of sobering-up composition

Similar Documents

Publication Publication Date Title
US20050129827A1 (en) Nutraceuticals and methods of obtaining nutraceuticals from tropical crops
EP1002540B1 (en) Composition comprising panax pseudo ginseng and eucommiae ulmoides
WO2015189857A1 (en) Green coffee bean extract and method thereof
WO2012081675A1 (en) Hops oxidation product, and production method and use therefor
JPH05246866A (en) Agent for stimulating cerebral metabolism and for improving cerebral function
Suhendi Potential Activity of Rambutan (Nepheliumlappaceum L.) Fruit Peel Extract as Antidiabetic and Antihypercholesterolemia
JPH0840923A (en) Nutrient-supplying agent
JPH05246873A (en) Agent for improving hepatic function and for preventing hangover
JP4974553B2 (en) Acetaldehyde metabolism promoter
JP2724524B2 (en) Constipation improvement / treatment agent
JP7244945B2 (en) Uses of Antrodia cinnamomum to relieve drunkenness and/or increase alcohol metabolism
JP3167777B2 (en) Antiviral, antibacterial and bactericide
US8709504B2 (en) Apoptosis inductor extracted from potato, potato foodstuff containing the inductor, and processed product thereof
JPH05246875A (en) Agent for improving and treating diabetes
JP3154544B2 (en) Inflammatory disease improving therapeutic agent
JPH05246871A (en) Agent for improving and treating anemia
JPH05271057A (en) Improving and curing agent for rheumatism
JPH05271058A (en) Improving and curing agent for cataract
JP2016108265A (en) Persistent antioxidant
KR100873393B1 (en) Granular of Gastrodiae rhizom powder using Gastrodiae rhizoma
JPH05271061A (en) Carcinostatic anticancer agent
CA2291974C (en) Composition comprising panax pseudo ginseng and eucommiae ulmoides
JPH069357A (en) Agent for removing body smell and bad smell of excreta
JPH05246868A (en) Therapeutic agent for improving and stabilizing blood pressure
JPH07215885A (en) Expectorant